May 5, 2026 07:22AM
Apr 30, 2026 06:54AM
Apr 29, 2026 07:00AM
Apr 19, 2026 10:00AM
Apr 14, 2026 06:48AM
Apr 13, 2026 03:07PM
Mar 27, 2026 06:47AM H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)
Mar 24, 2026 04:23AM
Mar 18, 2026 09:21AM
Mar 2, 2026 04:01PM
Mar 2, 2026 10:19AM
Feb 20, 2026 07:53AM
Feb 19, 2026 02:01PM
Feb 19, 2026 10:41AM Ocular Therapeutix Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Feb 5, 2026 08:55AM
Feb 5, 2026 07:43AM
Jan 15, 2026 10:01AM
Jan 13, 2026 04:59AM
Dec 18, 2025 06:24AM
Dec 17, 2025 10:43AM
Dec 16, 2025 08:38AM TD Cowen on Ocular Therapeutix (OCUL): 'Great Data Could Lead To 45% Upside Per Investor Survey'
Dec 16, 2025 04:21AM
Dec 9, 2025 04:00AM
Dec 8, 2025 07:02AM
Dec 8, 2025 06:46AM
Dec 8, 2025 05:08AM
Dec 8, 2025 04:34AM
Nov 5, 2025 10:02AM Ocular Therapeutix (OCUL) PT Raised at RBC Capital; 'DR May Offer Additional Upside Potential'
Nov 4, 2025 07:12AM
Nov 4, 2025 07:02AM
Oct 30, 2025 09:38AM
Oct 8, 2025 06:45AM
Oct 3, 2025 08:19AM
Oct 1, 2025 04:29AM
Sep 30, 2025 06:21AM Ocular Therapeutix hosts investor day detailing AXPAXLI trial progress
Sep 30, 2025 06:15AM
Sep 15, 2025 05:07AM
Aug 12, 2025 07:01AM
Aug 5, 2025 12:45PM
Aug 5, 2025 11:11AM
Aug 5, 2025 11:07AM
Aug 5, 2025 07:13AM Ocular Therapeutix (OCUL) Misses Q2 EPS by 4c
Aug 4, 2025 01:18PM
May 30, 2025 06:43AM
May 28, 2025 03:47PM
May 5, 2025 09:48AM
May 5, 2025 07:04AM
Apr 23, 2025 04:22AM
Apr 8, 2025 07:59AM William Blair Starts Ocular Therapeutix (OCUL) at Outperform, 'we believe Axpaxli has the potential to show best-in-class efficacy and durability'
Mar 26, 2025 06:55AM

413,562 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All